Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele

Annals of Neurology

Volumn 51, Issue 2, 2002, Pages 209-214

  Mori, Etsuro ^a,c   Lee, Kanguk ^a   Yasuda, Minoru ^a   Hashimoto, Mamoru ^a   Kazui, Hiroaki ^b   Hirono, Nobutsugu ^a   Matsui, Mieko ^a  

^a Hyogo Institute for Aging Brain and Cognitive Disorders   (Japan)

^b Seoul National University   (South Korea)

^c Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ATROPHY; DISEASE PROGRESSION; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0036152408     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10093     Document Type: Article

References (37)

1. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
2. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease
3. No association between apolipoprotein E epsilon4 allele and rate of decline in Alzheimer's disease
4. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
5. Apolipoprotein E epsilon4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease
6. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease
7. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease
8. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease
9. Longitudinal SPECT study in Alzheimer's disease: Relation to apolipoprotein E polymorphism
10. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions
11. MR based hippocampal volumetry in the diagnosis of Alzheimer's disease
12. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
13. SPECT and MRI analysis in Alzheimer's disease: Relation to apolipoprotein E ε4 allele
14. Apolipoprotein E, memory and Alzheimer's disease
15. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease
16. Apolipoprotein E epsilon4 allele and whole brain atrophy in late-onset Alzheimer's disease
17. ApoE- ε4 is associated with less frontal and more medial temporal lobe atrophy in AD
18. Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer's disease
19. Clinical diagnosis of dementia with Lewy bodies in a Japanese Dementia Registry
20. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
21. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
22. The Alzheimer's disease Assessment Scale: An instrument for assessing treatment efficacy
23. The clinical dementia rating (CDR): Current version and scoring rules
24. Medial temporal structures related to memory impairment in Alzheimer's disease: An MRI volumetric study
25. Amygdalar volume and emotional memory in Alzheimer's disease
26. Medial temporal and whole-brain atrophy in dementia with Lewy bodies. A volumetric MRI study
27. MRI-based hippocampal volume measurements in epilepsy
28. Automated segmentation of human brain MR images aided by fuzzy information granulation and fuzzy inference
29. Frontotemporal dementia and Alzheimer disease: Evaluation of cortical atrophy with automated hemispheric surface display generated with MR images
30. Apolipoprotein E genotyping by one-stage PCR
31. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype
32. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease
33. Apolipoprotein E epsilon4 allele and hippocampal volume in twins with normal cognition
34. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
35. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: Relation to apolipoprotein E polymorphism
36. Apolipoprotein E genotype influences cognitive phenotype in patients with Alzheimer's disease but not in healthy control subjects
37. Lack of association of apolipoprotein E ε4 allele dose with cerebral glucose metabolism in Alzheimer disease